Apixaban trials for Atrial fibrillation

All Apixaban trials · All Atrial fibrillation trials

Phase breakdown

Recruiting trials studying Apixaban for Atrial fibrillation

• Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
  NCT03907046 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 187 locations
• Apixaban Safety and Therapy Adherence in Patients With Atrial Fibrillation
  NCT07458191 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation
  NCT04642430 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• Comparing the Safety and Efficacy of Apixaban and Rivaroxaban
  NCT06953726 · Phase: Phase 4 · Ages: 65 Years and older · Sex: All (male and female) · 5 locations
• Net Clinical Benefit of Edoxaban Versus Apixaban in Patients With Atrial Fibrillation and Coronary Artery Disease
  NCT07753200 · Phase: Phase 4 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
  NCT07175428 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 81 locations
• Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation
  NCT06486792 · Phase: Phase 4 · Ages: 65 Years and older · Sex: All (male and female) · 1 location
• Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
  NCT07626411 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 32 locations

Common questions

How many trials study Apixaban for Atrial fibrillation?

8 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.